Consistent with these studies, we confirmed that Rhbdf2 levels were significantly increased in livers of human patients with NASH and simple steatosis phenotypes, as compared to the levels in non-steatosis samples. Here, RHBDF2 is linked to metabolic dysfunction-associated steatohepatitis.